Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-20
2006-06-20
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S469000
Reexamination Certificate
active
07064143
ABSTRACT:
Compounds of Formula Iwherein R1, R2, R3, R4, R5, W and X as defined in the specification, enantiomers thereof, pharmaceutically-acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially for treatment of conditions associated with reductions in nicotinic transmission. Compounds of the invention enhance the efficacy of agonists at nicotinic receptors.
REFERENCES:
patent: 5690697 (1997-11-01), Samain
patent: 0237781 (1987-09-01), None
patent: 0722941 (1996-07-01), None
patent: 1310235 (1973-03-01), None
patent: WO 9205170 (1992-04-01), None
patent: WO 9311106 (1993-06-01), None
patent: WO 9318026 (1993-09-01), None
patent: WO 9530655 (1995-11-01), None
Goodman & Gilman's, The Pharmaceutical Basis of Therapeutics, 10thEdition, 2001, p. 549.
Phytochemistry, vol. 11, 1972, Yasuyoshi Torigoe et al, “Cytokinin Activity of Azaindene, Azanaphthalene, Naphthalene, and Indole Derivatives”, p. 1623-p. 1630, see compounds (XIII) and (XIV), p. 1625.
Chemical Abstracts, vol. 57 (), (Columbus, Ohio, USA), E. Piers et al, The synthesis of mercaptoindoles, The Abstract No. 15053h, Can. J. Chem. 1962, 40, 511-517.
Gurley David
Rosamond James
AstraZeneca AB
Mitchell Kenneth F.
Saeed Kamal A.
LandOfFree
Positive modulators of nicotinic receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Positive modulators of nicotinic receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Positive modulators of nicotinic receptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3703446